Европейский союз - датский - EMA (European Medicines Agency)

mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotiske midler - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

aurobindo pharma (malta) limited - efavirenz - filmovertrukne tabletter - 600 mg

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

aspen pharma trading limited - ropivacainhydrochlorid (vandfri) - injektionsvæske, opløsning - 10 mg/ml

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

aspen pharma trading limited - ropivacainhydrochlorid (vandfri) - injektionsvæske, opløsning - 2 mg/ml

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

aspen pharma trading limited - ropivacainhydrochlorid (vandfri) - injektionsvæske, opløsning - 7,5 mg/ml

Европейский союз - датский - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - fluticason furoate - rhinitis, allergic, seasonal; rhinitis, allergic, perennial - nasal præparater, kortikosteroider - voksne, unge (12 år og derover) og børn (6-11 år). avamys er indiceret til behandling af symptomerne på allergisk rhinitis.

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

aspen pharma trading limited - lidocain, prilocain - creme - 25+25 mg/g

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

aurobindo pharma (malta) limited - fluconazol - kapsler, hårde - 50 mg

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

aspen pharma trading limited - ropivacainhydrochlorid (vandfri) - infusionsvæske, opløsning - 2 mg/ml

Европейский союз - датский - EMA (European Medicines Agency)

norbrook laboratories (ireland) limited - meloxicam - anti-inflammatory and anti-rheumatic products, non-steroids - dogs; cats; cattle; pigs - dogsalleviation af betændelse og smerter i både akutte og kroniske muskuloskeletale lidelser. at reducere postoperativ smerte og betændelse efter ortopædisk og blødvævkirurgi. catsalleviation af betændelse og smerter i kroniske sygdomme i bevægeapparatet hos katte. at reducere postoperativ smerte efter ovariohysterektomi og mindre blødvævkirurgi. cattlefor brug i akut respiratorisk infektion med passende antibiotisk behandling for at reducere kliniske symptomer hos kvæg. til brug i diarré i kombination med oral rehydreringsterapi for at reducere kliniske tegn i kalve på over en uge og unge, ikke-lakterende kvæg. til supplerende terapi til behandling af akut mastitis i kombination med antibiotikabehandling. pigsfor brug i infektiøse lidelser i bevægeapparatet til at reducere symptomer på halthed og inflammation. til supplerende terapi ved behandling af puerperal septikæmi og toksæmi (mastitis-metritis-agalactia syndrom) med passende antibiotikabehandling. horsesfor brug i lindring af betændelse og lindring af smerter i både akutte og kroniske muskuloskeletale lidelser. til lindring af smerte forbundet med hestekolik.